Global Oncology Drugs Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Oncology Drugs market size is predicted to grow from US$ 234640 million in 2025 to US$ 431450 million in 2031; it is expected to grow at a CAGR of 10.7% from 2025 to 2031.
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.
LPI (LP Information)' newest research report, the “Oncology Drugs Industry Forecast” looks at past sales and reviews total world Oncology Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Oncology Drugs sales for 2025 through 2031. With Oncology Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Drugs industry.
This Insight Report provides a comprehensive analysis of the global Oncology Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncology Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Oncology Drugs market size is predicted to grow from US$ 234640 million in 2025 to US$ 431450 million in 2031; it is expected to grow at a CAGR of 10.7% from 2025 to 2031.
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.
LPI (LP Information)' newest research report, the “Oncology Drugs Industry Forecast” looks at past sales and reviews total world Oncology Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Oncology Drugs sales for 2025 through 2031. With Oncology Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Drugs industry.
This Insight Report provides a comprehensive analysis of the global Oncology Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncology Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Chemotherapy
- Targeted Therapy
- Immunotherapy (Biologic Therapy)
- Hormonal Therapy
- Others
- Blood Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Respiratory or Lung Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Celgene
- Novartis
- Bristol-Myers Squibb
- Johnson & Johnson
- Merck & Co.
- AstraZeneca
- Pfizer
- Amgen
- Eli Lilly
- AbbVie
- Takeda
- Astellas
- Ipsen
- Sanofi
- Bayer
- Biogen Idec
- Teva
- Otsuka
- Eisai
- Merck KGaA
- Gilead Sciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Drugs Market Size (2020-2031)
2.1.2 Oncology Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Oncology Drugs by Country/Region (2020, 2024 & 2031)
2.2 Oncology Drugs Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy (Biologic Therapy)
2.2.4 Hormonal Therapy
2.2.5 Others
2.3 Oncology Drugs Market Size by Type
2.3.1 Oncology Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Oncology Drugs Market Size Market Share by Type (2020-2025)
2.4 Oncology Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory or Lung Cancer
2.4.6 Others
2.5 Oncology Drugs Market Size by Application
2.5.1 Oncology Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Oncology Drugs Market Size Market Share by Application (2020-2025)
3 ONCOLOGY DRUGS MARKET SIZE BY PLAYER
3.1 Oncology Drugs Market Size Market Share by Player
3.1.1 Global Oncology Drugs Revenue by Player (2020-2025)
3.1.2 Global Oncology Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Oncology Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLOGY DRUGS BY REGION
4.1 Oncology Drugs Market Size by Region (2020-2025)
4.2 Global Oncology Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oncology Drugs Market Size Growth (2020-2025)
4.4 APAC Oncology Drugs Market Size Growth (2020-2025)
4.5 Europe Oncology Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Oncology Drugs Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Oncology Drugs Market Size by Country (2020-2025)
5.2 Americas Oncology Drugs Market Size by Type (2020-2025)
5.3 Americas Oncology Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Drugs Market Size by Region (2020-2025)
6.2 APAC Oncology Drugs Market Size by Type (2020-2025)
6.3 APAC Oncology Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncology Drugs Market Size by Country (2020-2025)
7.2 Europe Oncology Drugs Market Size by Type (2020-2025)
7.3 Europe Oncology Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Drugs by Region (2020-2025)
8.2 Middle East & Africa Oncology Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Oncology Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLOGY DRUGS MARKET FORECAST
10.1 Global Oncology Drugs Forecast by Region (2026-2031)
10.1.1 Global Oncology Drugs Forecast by Region (2026-2031)
10.1.2 Americas Oncology Drugs Forecast
10.1.3 APAC Oncology Drugs Forecast
10.1.4 Europe Oncology Drugs Forecast
10.1.5 Middle East & Africa Oncology Drugs Forecast
10.2 Americas Oncology Drugs Forecast by Country (2026-2031)
10.2.1 United States Market Oncology Drugs Forecast
10.2.2 Canada Market Oncology Drugs Forecast
10.2.3 Mexico Market Oncology Drugs Forecast
10.2.4 Brazil Market Oncology Drugs Forecast
10.3 APAC Oncology Drugs Forecast by Region (2026-2031)
10.3.1 China Oncology Drugs Market Forecast
10.3.2 Japan Market Oncology Drugs Forecast
10.3.3 Korea Market Oncology Drugs Forecast
10.3.4 Southeast Asia Market Oncology Drugs Forecast
10.3.5 India Market Oncology Drugs Forecast
10.3.6 Australia Market Oncology Drugs Forecast
10.4 Europe Oncology Drugs Forecast by Country (2026-2031)
10.4.1 Germany Market Oncology Drugs Forecast
10.4.2 France Market Oncology Drugs Forecast
10.4.3 UK Market Oncology Drugs Forecast
10.4.4 Italy Market Oncology Drugs Forecast
10.4.5 Russia Market Oncology Drugs Forecast
10.5 Middle East & Africa Oncology Drugs Forecast by Region (2026-2031)
10.5.1 Egypt Market Oncology Drugs Forecast
10.5.2 South Africa Market Oncology Drugs Forecast
10.5.3 Israel Market Oncology Drugs Forecast
10.5.4 Turkey Market Oncology Drugs Forecast
10.6 Global Oncology Drugs Forecast by Type (2026-2031)
10.7 Global Oncology Drugs Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Oncology Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Oncology Drugs Product Offered
11.1.3 Roche Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Celgene
11.2.1 Celgene Company Information
11.2.2 Celgene Oncology Drugs Product Offered
11.2.3 Celgene Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Celgene Main Business Overview
11.2.5 Celgene Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Oncology Drugs Product Offered
11.3.3 Novartis Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Oncology Drugs Product Offered
11.4.3 Bristol-Myers Squibb Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Oncology Drugs Product Offered
11.5.3 Johnson & Johnson Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Merck & Co.
11.6.1 Merck & Co. Company Information
11.6.2 Merck & Co. Oncology Drugs Product Offered
11.6.3 Merck & Co. Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Merck & Co. Main Business Overview
11.6.5 Merck & Co. Latest Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Oncology Drugs Product Offered
11.7.3 AstraZeneca Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 AstraZeneca Main Business Overview
11.7.5 AstraZeneca Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Oncology Drugs Product Offered
11.8.3 Pfizer Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Oncology Drugs Product Offered
11.9.3 Amgen Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Oncology Drugs Product Offered
11.10.3 Eli Lilly Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11.11 AbbVie
11.11.1 AbbVie Company Information
11.11.2 AbbVie Oncology Drugs Product Offered
11.11.3 AbbVie Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 AbbVie Main Business Overview
11.11.5 AbbVie Latest Developments
11.12 Takeda
11.12.1 Takeda Company Information
11.12.2 Takeda Oncology Drugs Product Offered
11.12.3 Takeda Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Takeda Main Business Overview
11.12.5 Takeda Latest Developments
11.13 Astellas
11.13.1 Astellas Company Information
11.13.2 Astellas Oncology Drugs Product Offered
11.13.3 Astellas Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Astellas Main Business Overview
11.13.5 Astellas Latest Developments
11.14 Ipsen
11.14.1 Ipsen Company Information
11.14.2 Ipsen Oncology Drugs Product Offered
11.14.3 Ipsen Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Ipsen Main Business Overview
11.14.5 Ipsen Latest Developments
11.15 Sanofi
11.15.1 Sanofi Company Information
11.15.2 Sanofi Oncology Drugs Product Offered
11.15.3 Sanofi Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Sanofi Main Business Overview
11.15.5 Sanofi Latest Developments
11.16 Bayer
11.16.1 Bayer Company Information
11.16.2 Bayer Oncology Drugs Product Offered
11.16.3 Bayer Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Bayer Main Business Overview
11.16.5 Bayer Latest Developments
11.17 Biogen Idec
11.17.1 Biogen Idec Company Information
11.17.2 Biogen Idec Oncology Drugs Product Offered
11.17.3 Biogen Idec Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Biogen Idec Main Business Overview
11.17.5 Biogen Idec Latest Developments
11.18 Teva
11.18.1 Teva Company Information
11.18.2 Teva Oncology Drugs Product Offered
11.18.3 Teva Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Teva Main Business Overview
11.18.5 Teva Latest Developments
11.19 Otsuka
11.19.1 Otsuka Company Information
11.19.2 Otsuka Oncology Drugs Product Offered
11.19.3 Otsuka Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Otsuka Main Business Overview
11.19.5 Otsuka Latest Developments
11.20 Eisai
11.20.1 Eisai Company Information
11.20.2 Eisai Oncology Drugs Product Offered
11.20.3 Eisai Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Eisai Main Business Overview
11.20.5 Eisai Latest Developments
11.21 Merck KGaA
11.21.1 Merck KGaA Company Information
11.21.2 Merck KGaA Oncology Drugs Product Offered
11.21.3 Merck KGaA Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Merck KGaA Main Business Overview
11.21.5 Merck KGaA Latest Developments
11.22 Gilead Sciences
11.22.1 Gilead Sciences Company Information
11.22.2 Gilead Sciences Oncology Drugs Product Offered
11.22.3 Gilead Sciences Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Gilead Sciences Main Business Overview
11.22.5 Gilead Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Oncology Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oncology Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Chemotherapy
Table 4. Major Players ofTargetedTherapy
Table 5. Major Players of Immunotherapy (BiologicTherapy)
Table 6. Major Players of HormonalTherapy
Table 7. Major Players of Others
Table 8. Oncology Drugs Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Oncology Drugs Market Size byType (2020-2025) & ($ millions)
Table 10. Global Oncology Drugs Market Size Market Share byType (2020-2025)
Table 11. Oncology Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Oncology Drugs Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Oncology Drugs Market Size Market Share by Application (2020-2025)
Table 14. Global Oncology Drugs Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Oncology Drugs Revenue Market Share by Player (2020-2025)
Table 16. Oncology Drugs Key Players Head office and Products Offered
Table 17. Oncology Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Oncology Drugs Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Oncology Drugs Market Size Market Share by Region (2020-2025)
Table 22. Global Oncology Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Oncology Drugs Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Oncology Drugs Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Oncology Drugs Market Size Market Share by Country (2020-2025)
Table 26. Americas Oncology Drugs Market Size byType (2020-2025) & ($ millions)
Table 27. Americas Oncology Drugs Market Size Market Share byType (2020-2025)
Table 28. Americas Oncology Drugs Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Oncology Drugs Market Size Market Share by Application (2020-2025)
Table 30. APAC Oncology Drugs Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Oncology Drugs Market Size Market Share by Region (2020-2025)
Table 32. APAC Oncology Drugs Market Size byType (2020-2025) & ($ millions)
Table 33. APAC Oncology Drugs Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Oncology Drugs Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Oncology Drugs Market Size Market Share by Country (2020-2025)
Table 36. Europe Oncology Drugs Market Size byType (2020-2025) & ($ millions)
Table 37. Europe Oncology Drugs Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Oncology Drugs Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Oncology Drugs Market Size byType (2020-2025) & ($ millions)
Table 40. Middle East & Africa Oncology Drugs Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Oncology Drugs
Table 42. Key Market Challenges & Risks of Oncology Drugs
Table 43. Key IndustryTrends of Oncology Drugs
Table 44. Global Oncology Drugs Market SizeForecast by Region (2026-2031) & ($ millions)
Table 45. Global Oncology Drugs Market Size Market ShareForecast by Region (2026-2031)
Table 46. Global Oncology Drugs Market SizeForecast byType (2026-2031) & ($ millions)
Table 47. Global Oncology Drugs Market SizeForecast by Application (2026-2031) & ($ millions)
Table 48. Roche Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 49. Roche Oncology Drugs Product Offered
Table 50. Roche Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Roche Main Business
Table 52. Roche Latest Developments
Table 53. Celgene Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 54. Celgene Oncology Drugs Product Offered
Table 55. Celgene Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Celgene Main Business
Table 57. Celgene Latest Developments
Table 58. Novartis Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 59. Novartis Oncology Drugs Product Offered
Table 60. Novartis Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Novartis Main Business
Table 62. Novartis Latest Developments
Table 63. Bristol-Myers Squibb Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 64. Bristol-Myers Squibb Oncology Drugs Product Offered
Table 65. Bristol-Myers Squibb Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Bristol-Myers Squibb Main Business
Table 67. Bristol-Myers Squibb Latest Developments
Table 68. Johnson & Johnson Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 69. Johnson & Johnson Oncology Drugs Product Offered
Table 70. Johnson & Johnson Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Johnson & Johnson Main Business
Table 72. Johnson & Johnson Latest Developments
Table 73. Merck & Co. Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 74. Merck & Co. Oncology Drugs Product Offered
Table 75. Merck & Co. Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Merck & Co. Main Business
Table 77. Merck & Co. Latest Developments
Table 78. AstraZeneca Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 79. AstraZeneca Oncology Drugs Product Offered
Table 80. AstraZeneca Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. AstraZeneca Main Business
Table 82. AstraZeneca Latest Developments
Table 83. Pfizer Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 84. Pfizer Oncology Drugs Product Offered
Table 85. Pfizer Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Amgen Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 89. Amgen Oncology Drugs Product Offered
Table 90. Amgen Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Amgen Main Business
Table 92. Amgen Latest Developments
Table 93. Eli Lilly Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 94. Eli Lilly Oncology Drugs Product Offered
Table 95. Eli Lilly Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Eli Lilly Main Business
Table 97. Eli Lilly Latest Developments
Table 98. AbbVie Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 99. AbbVie Oncology Drugs Product Offered
Table 100. AbbVie Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. AbbVie Main Business
Table 102. AbbVie Latest Developments
Table 103.Takeda Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 104.Takeda Oncology Drugs Product Offered
Table 105.Takeda Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106.Takeda Main Business
Table 107.Takeda Latest Developments
Table 108. Astellas Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 109. Astellas Oncology Drugs Product Offered
Table 110. Astellas Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Astellas Main Business
Table 112. Astellas Latest Developments
Table 113. Ipsen Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 114. Ipsen Oncology Drugs Product Offered
Table 115. Ipsen Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. Ipsen Main Business
Table 117. Ipsen Latest Developments
Table 118. Sanofi Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 119. Sanofi Oncology Drugs Product Offered
Table 120. Sanofi Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. Sanofi Main Business
Table 122. Sanofi Latest Developments
Table 123. Bayer Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 124. Bayer Oncology Drugs Product Offered
Table 125. Bayer Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 126. Bayer Main Business
Table 127. Bayer Latest Developments
Table 128. Biogen Idec Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 129. Biogen Idec Oncology Drugs Product Offered
Table 130. Biogen Idec Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 131. Biogen Idec Main Business
Table 132. Biogen Idec Latest Developments
Table 133.Teva Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 134.Teva Oncology Drugs Product Offered
Table 135.Teva Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 136.Teva Main Business
Table 137.Teva Latest Developments
Table 138. Otsuka Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 139. Otsuka Oncology Drugs Product Offered
Table 140. Otsuka Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 141. Otsuka Main Business
Table 142. Otsuka Latest Developments
Table 143. Eisai Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 144. Eisai Oncology Drugs Product Offered
Table 145. Eisai Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 146. Eisai Main Business
Table 147. Eisai Latest Developments
Table 148. Merck KGaA Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 149. Merck KGaA Oncology Drugs Product Offered
Table 150. Merck KGaA Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 151. Merck KGaA Main Business
Table 152. Merck KGaA Latest Developments
Table 153. Gilead Sciences Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 154. Gilead Sciences Oncology Drugs Product Offered
Table 155. Gilead Sciences Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 156. Gilead Sciences Main Business
Table 157. Gilead Sciences Latest Developments
LIST OFFIGURES
Figure 1. Oncology Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oncology Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oncology Drugs Sales Market Share by Country/Region (2024)
Figure 8. Oncology Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oncology Drugs Market Size Market Share byType in 2024
Figure 10. Oncology Drugs in Blood Cancer
Figure 11. Global Oncology Drugs Market: Blood Cancer (2020-2025) & ($ millions)
Figure 12. Oncology Drugs in Breast Cancer
Figure 13. Global Oncology Drugs Market: Breast Cancer (2020-2025) & ($ millions)
Figure 14. Oncology Drugs in Gastrointestinal Cancer
Figure 15. Global Oncology Drugs Market: Gastrointestinal Cancer (2020-2025) & ($ millions)
Figure 16. Oncology Drugs in Prostate Cancer
Figure 17. Global Oncology Drugs Market: Prostate Cancer (2020-2025) & ($ millions)
Figure 18. Oncology Drugs in Respiratory or Lung Cancer
Figure 19. Global Oncology Drugs Market: Respiratory or Lung Cancer (2020-2025) & ($ millions)
Figure 20. Oncology Drugs in Others
Figure 21. Global Oncology Drugs Market: Others (2020-2025) & ($ millions)
Figure 22. Global Oncology Drugs Market Size Market Share by Application in 2024
Figure 23. Global Oncology Drugs Revenue Market Share by Player in 2024
Figure 24. Global Oncology Drugs Market Size Market Share by Region (2020-2025)
Figure 25. Americas Oncology Drugs Market Size 2020-2025 ($ millions)
Figure 26. APAC Oncology Drugs Market Size 2020-2025 ($ millions)
Figure 27. Europe Oncology Drugs Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa Oncology Drugs Market Size 2020-2025 ($ millions)
Figure 29. Americas Oncology Drugs Value Market Share by Country in 2024
Figure 30. United States Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC Oncology Drugs Market Size Market Share by Region in 2024
Figure 35. APAC Oncology Drugs Market Size Market Share byType (2020-2025)
Figure 36. APAC Oncology Drugs Market Size Market Share by Application (2020-2025)
Figure 37. China Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 41. India Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe Oncology Drugs Market Size Market Share by Country in 2024
Figure 44. Europe Oncology Drugs Market Size Market Share byType (2020-2025)
Figure 45. Europe Oncology Drugs Market Size Market Share by Application (2020-2025)
Figure 46. Germany Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 47.France Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 48. UK Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa Oncology Drugs Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa Oncology Drugs Market Size Market Share byType (2020-2025)
Figure 53. Middle East & Africa Oncology Drugs Market Size Market Share by Application (2020-2025)
Figure 54. Egypt Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 57.Turkey Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 60. APAC Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 61. Europe Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 63. United States Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 64. Canada Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 65. Mexico Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 66. Brazil Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 67. China Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 68. Japan Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 69. Korea Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 71. India Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 72. Australia Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 73. Germany Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 74.France Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 75. UK Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 76. Italy Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 77. Russia Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 78. Egypt Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 79. South Africa Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 80. Israel Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 81.Turkey Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 82. Global Oncology Drugs Market Size Market ShareForecast byType (2026-2031)
Figure 83. Global Oncology Drugs Market Size Market ShareForecast by Application (2026-2031)
Figure 84. GCC Countries Oncology Drugs Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Drugs Market Size (2020-2031)
2.1.2 Oncology Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Oncology Drugs by Country/Region (2020, 2024 & 2031)
2.2 Oncology Drugs Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy (Biologic Therapy)
2.2.4 Hormonal Therapy
2.2.5 Others
2.3 Oncology Drugs Market Size by Type
2.3.1 Oncology Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Oncology Drugs Market Size Market Share by Type (2020-2025)
2.4 Oncology Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory or Lung Cancer
2.4.6 Others
2.5 Oncology Drugs Market Size by Application
2.5.1 Oncology Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Oncology Drugs Market Size Market Share by Application (2020-2025)
3 ONCOLOGY DRUGS MARKET SIZE BY PLAYER
3.1 Oncology Drugs Market Size Market Share by Player
3.1.1 Global Oncology Drugs Revenue by Player (2020-2025)
3.1.2 Global Oncology Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Oncology Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLOGY DRUGS BY REGION
4.1 Oncology Drugs Market Size by Region (2020-2025)
4.2 Global Oncology Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oncology Drugs Market Size Growth (2020-2025)
4.4 APAC Oncology Drugs Market Size Growth (2020-2025)
4.5 Europe Oncology Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Oncology Drugs Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Oncology Drugs Market Size by Country (2020-2025)
5.2 Americas Oncology Drugs Market Size by Type (2020-2025)
5.3 Americas Oncology Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Drugs Market Size by Region (2020-2025)
6.2 APAC Oncology Drugs Market Size by Type (2020-2025)
6.3 APAC Oncology Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncology Drugs Market Size by Country (2020-2025)
7.2 Europe Oncology Drugs Market Size by Type (2020-2025)
7.3 Europe Oncology Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Drugs by Region (2020-2025)
8.2 Middle East & Africa Oncology Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Oncology Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLOGY DRUGS MARKET FORECAST
10.1 Global Oncology Drugs Forecast by Region (2026-2031)
10.1.1 Global Oncology Drugs Forecast by Region (2026-2031)
10.1.2 Americas Oncology Drugs Forecast
10.1.3 APAC Oncology Drugs Forecast
10.1.4 Europe Oncology Drugs Forecast
10.1.5 Middle East & Africa Oncology Drugs Forecast
10.2 Americas Oncology Drugs Forecast by Country (2026-2031)
10.2.1 United States Market Oncology Drugs Forecast
10.2.2 Canada Market Oncology Drugs Forecast
10.2.3 Mexico Market Oncology Drugs Forecast
10.2.4 Brazil Market Oncology Drugs Forecast
10.3 APAC Oncology Drugs Forecast by Region (2026-2031)
10.3.1 China Oncology Drugs Market Forecast
10.3.2 Japan Market Oncology Drugs Forecast
10.3.3 Korea Market Oncology Drugs Forecast
10.3.4 Southeast Asia Market Oncology Drugs Forecast
10.3.5 India Market Oncology Drugs Forecast
10.3.6 Australia Market Oncology Drugs Forecast
10.4 Europe Oncology Drugs Forecast by Country (2026-2031)
10.4.1 Germany Market Oncology Drugs Forecast
10.4.2 France Market Oncology Drugs Forecast
10.4.3 UK Market Oncology Drugs Forecast
10.4.4 Italy Market Oncology Drugs Forecast
10.4.5 Russia Market Oncology Drugs Forecast
10.5 Middle East & Africa Oncology Drugs Forecast by Region (2026-2031)
10.5.1 Egypt Market Oncology Drugs Forecast
10.5.2 South Africa Market Oncology Drugs Forecast
10.5.3 Israel Market Oncology Drugs Forecast
10.5.4 Turkey Market Oncology Drugs Forecast
10.6 Global Oncology Drugs Forecast by Type (2026-2031)
10.7 Global Oncology Drugs Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Oncology Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Oncology Drugs Product Offered
11.1.3 Roche Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Celgene
11.2.1 Celgene Company Information
11.2.2 Celgene Oncology Drugs Product Offered
11.2.3 Celgene Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Celgene Main Business Overview
11.2.5 Celgene Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Oncology Drugs Product Offered
11.3.3 Novartis Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Oncology Drugs Product Offered
11.4.3 Bristol-Myers Squibb Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Oncology Drugs Product Offered
11.5.3 Johnson & Johnson Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Merck & Co.
11.6.1 Merck & Co. Company Information
11.6.2 Merck & Co. Oncology Drugs Product Offered
11.6.3 Merck & Co. Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Merck & Co. Main Business Overview
11.6.5 Merck & Co. Latest Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Oncology Drugs Product Offered
11.7.3 AstraZeneca Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 AstraZeneca Main Business Overview
11.7.5 AstraZeneca Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Oncology Drugs Product Offered
11.8.3 Pfizer Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Oncology Drugs Product Offered
11.9.3 Amgen Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Oncology Drugs Product Offered
11.10.3 Eli Lilly Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11.11 AbbVie
11.11.1 AbbVie Company Information
11.11.2 AbbVie Oncology Drugs Product Offered
11.11.3 AbbVie Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 AbbVie Main Business Overview
11.11.5 AbbVie Latest Developments
11.12 Takeda
11.12.1 Takeda Company Information
11.12.2 Takeda Oncology Drugs Product Offered
11.12.3 Takeda Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Takeda Main Business Overview
11.12.5 Takeda Latest Developments
11.13 Astellas
11.13.1 Astellas Company Information
11.13.2 Astellas Oncology Drugs Product Offered
11.13.3 Astellas Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Astellas Main Business Overview
11.13.5 Astellas Latest Developments
11.14 Ipsen
11.14.1 Ipsen Company Information
11.14.2 Ipsen Oncology Drugs Product Offered
11.14.3 Ipsen Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Ipsen Main Business Overview
11.14.5 Ipsen Latest Developments
11.15 Sanofi
11.15.1 Sanofi Company Information
11.15.2 Sanofi Oncology Drugs Product Offered
11.15.3 Sanofi Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Sanofi Main Business Overview
11.15.5 Sanofi Latest Developments
11.16 Bayer
11.16.1 Bayer Company Information
11.16.2 Bayer Oncology Drugs Product Offered
11.16.3 Bayer Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Bayer Main Business Overview
11.16.5 Bayer Latest Developments
11.17 Biogen Idec
11.17.1 Biogen Idec Company Information
11.17.2 Biogen Idec Oncology Drugs Product Offered
11.17.3 Biogen Idec Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Biogen Idec Main Business Overview
11.17.5 Biogen Idec Latest Developments
11.18 Teva
11.18.1 Teva Company Information
11.18.2 Teva Oncology Drugs Product Offered
11.18.3 Teva Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Teva Main Business Overview
11.18.5 Teva Latest Developments
11.19 Otsuka
11.19.1 Otsuka Company Information
11.19.2 Otsuka Oncology Drugs Product Offered
11.19.3 Otsuka Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Otsuka Main Business Overview
11.19.5 Otsuka Latest Developments
11.20 Eisai
11.20.1 Eisai Company Information
11.20.2 Eisai Oncology Drugs Product Offered
11.20.3 Eisai Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Eisai Main Business Overview
11.20.5 Eisai Latest Developments
11.21 Merck KGaA
11.21.1 Merck KGaA Company Information
11.21.2 Merck KGaA Oncology Drugs Product Offered
11.21.3 Merck KGaA Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Merck KGaA Main Business Overview
11.21.5 Merck KGaA Latest Developments
11.22 Gilead Sciences
11.22.1 Gilead Sciences Company Information
11.22.2 Gilead Sciences Oncology Drugs Product Offered
11.22.3 Gilead Sciences Oncology Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Gilead Sciences Main Business Overview
11.22.5 Gilead Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Oncology Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oncology Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Chemotherapy
Table 4. Major Players ofTargetedTherapy
Table 5. Major Players of Immunotherapy (BiologicTherapy)
Table 6. Major Players of HormonalTherapy
Table 7. Major Players of Others
Table 8. Oncology Drugs Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Oncology Drugs Market Size byType (2020-2025) & ($ millions)
Table 10. Global Oncology Drugs Market Size Market Share byType (2020-2025)
Table 11. Oncology Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Oncology Drugs Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Oncology Drugs Market Size Market Share by Application (2020-2025)
Table 14. Global Oncology Drugs Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Oncology Drugs Revenue Market Share by Player (2020-2025)
Table 16. Oncology Drugs Key Players Head office and Products Offered
Table 17. Oncology Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Oncology Drugs Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Oncology Drugs Market Size Market Share by Region (2020-2025)
Table 22. Global Oncology Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Oncology Drugs Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Oncology Drugs Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Oncology Drugs Market Size Market Share by Country (2020-2025)
Table 26. Americas Oncology Drugs Market Size byType (2020-2025) & ($ millions)
Table 27. Americas Oncology Drugs Market Size Market Share byType (2020-2025)
Table 28. Americas Oncology Drugs Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Oncology Drugs Market Size Market Share by Application (2020-2025)
Table 30. APAC Oncology Drugs Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Oncology Drugs Market Size Market Share by Region (2020-2025)
Table 32. APAC Oncology Drugs Market Size byType (2020-2025) & ($ millions)
Table 33. APAC Oncology Drugs Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Oncology Drugs Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Oncology Drugs Market Size Market Share by Country (2020-2025)
Table 36. Europe Oncology Drugs Market Size byType (2020-2025) & ($ millions)
Table 37. Europe Oncology Drugs Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Oncology Drugs Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Oncology Drugs Market Size byType (2020-2025) & ($ millions)
Table 40. Middle East & Africa Oncology Drugs Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Oncology Drugs
Table 42. Key Market Challenges & Risks of Oncology Drugs
Table 43. Key IndustryTrends of Oncology Drugs
Table 44. Global Oncology Drugs Market SizeForecast by Region (2026-2031) & ($ millions)
Table 45. Global Oncology Drugs Market Size Market ShareForecast by Region (2026-2031)
Table 46. Global Oncology Drugs Market SizeForecast byType (2026-2031) & ($ millions)
Table 47. Global Oncology Drugs Market SizeForecast by Application (2026-2031) & ($ millions)
Table 48. Roche Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 49. Roche Oncology Drugs Product Offered
Table 50. Roche Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Roche Main Business
Table 52. Roche Latest Developments
Table 53. Celgene Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 54. Celgene Oncology Drugs Product Offered
Table 55. Celgene Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Celgene Main Business
Table 57. Celgene Latest Developments
Table 58. Novartis Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 59. Novartis Oncology Drugs Product Offered
Table 60. Novartis Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Novartis Main Business
Table 62. Novartis Latest Developments
Table 63. Bristol-Myers Squibb Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 64. Bristol-Myers Squibb Oncology Drugs Product Offered
Table 65. Bristol-Myers Squibb Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Bristol-Myers Squibb Main Business
Table 67. Bristol-Myers Squibb Latest Developments
Table 68. Johnson & Johnson Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 69. Johnson & Johnson Oncology Drugs Product Offered
Table 70. Johnson & Johnson Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Johnson & Johnson Main Business
Table 72. Johnson & Johnson Latest Developments
Table 73. Merck & Co. Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 74. Merck & Co. Oncology Drugs Product Offered
Table 75. Merck & Co. Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Merck & Co. Main Business
Table 77. Merck & Co. Latest Developments
Table 78. AstraZeneca Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 79. AstraZeneca Oncology Drugs Product Offered
Table 80. AstraZeneca Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. AstraZeneca Main Business
Table 82. AstraZeneca Latest Developments
Table 83. Pfizer Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 84. Pfizer Oncology Drugs Product Offered
Table 85. Pfizer Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Amgen Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 89. Amgen Oncology Drugs Product Offered
Table 90. Amgen Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Amgen Main Business
Table 92. Amgen Latest Developments
Table 93. Eli Lilly Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 94. Eli Lilly Oncology Drugs Product Offered
Table 95. Eli Lilly Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Eli Lilly Main Business
Table 97. Eli Lilly Latest Developments
Table 98. AbbVie Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 99. AbbVie Oncology Drugs Product Offered
Table 100. AbbVie Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. AbbVie Main Business
Table 102. AbbVie Latest Developments
Table 103.Takeda Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 104.Takeda Oncology Drugs Product Offered
Table 105.Takeda Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106.Takeda Main Business
Table 107.Takeda Latest Developments
Table 108. Astellas Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 109. Astellas Oncology Drugs Product Offered
Table 110. Astellas Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Astellas Main Business
Table 112. Astellas Latest Developments
Table 113. Ipsen Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 114. Ipsen Oncology Drugs Product Offered
Table 115. Ipsen Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. Ipsen Main Business
Table 117. Ipsen Latest Developments
Table 118. Sanofi Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 119. Sanofi Oncology Drugs Product Offered
Table 120. Sanofi Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. Sanofi Main Business
Table 122. Sanofi Latest Developments
Table 123. Bayer Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 124. Bayer Oncology Drugs Product Offered
Table 125. Bayer Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 126. Bayer Main Business
Table 127. Bayer Latest Developments
Table 128. Biogen Idec Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 129. Biogen Idec Oncology Drugs Product Offered
Table 130. Biogen Idec Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 131. Biogen Idec Main Business
Table 132. Biogen Idec Latest Developments
Table 133.Teva Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 134.Teva Oncology Drugs Product Offered
Table 135.Teva Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 136.Teva Main Business
Table 137.Teva Latest Developments
Table 138. Otsuka Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 139. Otsuka Oncology Drugs Product Offered
Table 140. Otsuka Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 141. Otsuka Main Business
Table 142. Otsuka Latest Developments
Table 143. Eisai Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 144. Eisai Oncology Drugs Product Offered
Table 145. Eisai Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 146. Eisai Main Business
Table 147. Eisai Latest Developments
Table 148. Merck KGaA Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 149. Merck KGaA Oncology Drugs Product Offered
Table 150. Merck KGaA Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 151. Merck KGaA Main Business
Table 152. Merck KGaA Latest Developments
Table 153. Gilead Sciences Details, CompanyType, Oncology Drugs Area Served and Its Competitors
Table 154. Gilead Sciences Oncology Drugs Product Offered
Table 155. Gilead Sciences Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 156. Gilead Sciences Main Business
Table 157. Gilead Sciences Latest Developments
LIST OFFIGURES
Figure 1. Oncology Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oncology Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oncology Drugs Sales Market Share by Country/Region (2024)
Figure 8. Oncology Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oncology Drugs Market Size Market Share byType in 2024
Figure 10. Oncology Drugs in Blood Cancer
Figure 11. Global Oncology Drugs Market: Blood Cancer (2020-2025) & ($ millions)
Figure 12. Oncology Drugs in Breast Cancer
Figure 13. Global Oncology Drugs Market: Breast Cancer (2020-2025) & ($ millions)
Figure 14. Oncology Drugs in Gastrointestinal Cancer
Figure 15. Global Oncology Drugs Market: Gastrointestinal Cancer (2020-2025) & ($ millions)
Figure 16. Oncology Drugs in Prostate Cancer
Figure 17. Global Oncology Drugs Market: Prostate Cancer (2020-2025) & ($ millions)
Figure 18. Oncology Drugs in Respiratory or Lung Cancer
Figure 19. Global Oncology Drugs Market: Respiratory or Lung Cancer (2020-2025) & ($ millions)
Figure 20. Oncology Drugs in Others
Figure 21. Global Oncology Drugs Market: Others (2020-2025) & ($ millions)
Figure 22. Global Oncology Drugs Market Size Market Share by Application in 2024
Figure 23. Global Oncology Drugs Revenue Market Share by Player in 2024
Figure 24. Global Oncology Drugs Market Size Market Share by Region (2020-2025)
Figure 25. Americas Oncology Drugs Market Size 2020-2025 ($ millions)
Figure 26. APAC Oncology Drugs Market Size 2020-2025 ($ millions)
Figure 27. Europe Oncology Drugs Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa Oncology Drugs Market Size 2020-2025 ($ millions)
Figure 29. Americas Oncology Drugs Value Market Share by Country in 2024
Figure 30. United States Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC Oncology Drugs Market Size Market Share by Region in 2024
Figure 35. APAC Oncology Drugs Market Size Market Share byType (2020-2025)
Figure 36. APAC Oncology Drugs Market Size Market Share by Application (2020-2025)
Figure 37. China Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 41. India Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe Oncology Drugs Market Size Market Share by Country in 2024
Figure 44. Europe Oncology Drugs Market Size Market Share byType (2020-2025)
Figure 45. Europe Oncology Drugs Market Size Market Share by Application (2020-2025)
Figure 46. Germany Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 47.France Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 48. UK Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa Oncology Drugs Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa Oncology Drugs Market Size Market Share byType (2020-2025)
Figure 53. Middle East & Africa Oncology Drugs Market Size Market Share by Application (2020-2025)
Figure 54. Egypt Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 57.Turkey Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries Oncology Drugs Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 60. APAC Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 61. Europe Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 63. United States Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 64. Canada Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 65. Mexico Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 66. Brazil Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 67. China Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 68. Japan Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 69. Korea Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 71. India Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 72. Australia Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 73. Germany Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 74.France Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 75. UK Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 76. Italy Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 77. Russia Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 78. Egypt Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 79. South Africa Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 80. Israel Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 81.Turkey Oncology Drugs Market Size 2026-2031 ($ millions)
Figure 82. Global Oncology Drugs Market Size Market ShareForecast byType (2026-2031)
Figure 83. Global Oncology Drugs Market Size Market ShareForecast by Application (2026-2031)
Figure 84. GCC Countries Oncology Drugs Market Size 2026-2031 ($ millions)
More Publications
Global Injection Port Septa Market Growth 2025-2031
US$ 3,660.00
April 2025
101 pages
Global Pharmacy Automation Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
January 2025
139 pages
Global Pediatric Urine Bags Market Growth 2024-2030
US$ 3,660.00
December 2024
110 pages
Global Nonwoven Filtration Market Growth 2024-2030
US$ 3,660.00
June 2024
152 pages
Global Human Vaccine Market Growth 2025-2031
US$ 3,660.00
January 2025
154 pages
